GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Radnor Capital Management LLC

Radnor Capital Management LLC grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,455 shares of the company’s stock after buying an additional 660 shares during the quarter. Radnor Capital Management LLC’s holdings in GE HealthCare Technologies were worth $763,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. CoreFirst Bank & Trust acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $25,000. Runnymede Capital Advisors Inc. acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $28,000. LGT Financial Advisors LLC increased its stake in shares of GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock valued at $30,000 after purchasing an additional 123 shares in the last quarter. Accredited Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $30,000. Finally, Ameriflex Group Inc. purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several recent analyst reports. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 31st. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their price target for the company from $74.00 to $73.00 in a research note on Monday, May 5th. The Goldman Sachs Group cut their price target on GE HealthCare Technologies from $94.00 to $82.00 and set a “buy” rating for the company in a research note on Thursday, May 1st. Evercore ISI cut their price target on GE HealthCare Technologies from $96.00 to $85.00 and set an “outperform” rating for the company in a research note on Thursday, May 1st. Finally, Wells Fargo & Company cut their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an “overweight” rating for the company in a research note on Thursday, May 1st. Three analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.27.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $71.62 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock has a 50 day moving average of $68.01 and a two-hundred day moving average of $78.69. The firm has a market cap of $32.79 billion, a P/E ratio of 16.54, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.10. The business had revenue of $4.78 billion during the quarter, compared to analyst estimates of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.90 earnings per share. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were given a $0.035 dividend. The ex-dividend date was Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.20%. GE HealthCare Technologies’s payout ratio is 2.95%.

GE HealthCare Technologies declared that its Board of Directors has authorized a stock repurchase program on Wednesday, April 30th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 3.1% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its stock is undervalued.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.